Azithromycin for infants at risk of poor growth and development: A pooled secondary analysis of two randomized controlled trials.

Azithromycin for infants at risk of poor growth and development: A pooled secondary analysis of two randomized controlled trials.

<h4>Background</h4>In 2023, the World Health Organization (WHO) revised its guidelines for management of severe acute malnutrition (SAM). The revised guidelines include a focus on infants at risk of poor growth and development. The guideline identifies evaluation of routine antibiotics f...

Full description

Saved in:
Bibliographic Details
Main Authors: Mamadou Bountogo, Mamadou Ouattara, Clarisse Dah, Boubacar Coulibaly, Thierry Ouedraogo, Alphonse Zakane, Valentin Boudo, Elodie Lebas, Huiyu Hu, Benjamin F Arnold, Thomas M Lietman, Ali Sié, Catherine E Oldenburg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0328208
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pone.0328208

Similar Items